Proteome-wide identification of NEDD8 modification sites reveals distinct proteomes for canonical and atypical NEDDylation.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
19 01 2021
Historique:
received: 21 01 2020
revised: 20 11 2020
accepted: 21 12 2020
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 29 1 2022
Statut: ppublish

Résumé

The ubiquitin-like molecule NEDD8 controls several biological processes and is a promising target for therapeutic intervention. NEDDylation occurs through specific NEDD8 enzymes (canonical) or enzymes of the ubiquitin system (atypical). Identification of NEDD8 sites on substrates is critical for delineating the processes controlled by NEDDylation. By combining the use of the NEDD8 R74K mutant with anti-di-glycine (anti-diGly) antibodies, we identified 1,101 unique NEDDylation sites in 620 proteins. Bioinformatics analysis reveals that canonical and atypical NEDDylation have distinct proteomes; the spliceosome/mRNA surveillance/DNA replication and ribosome/proteasome, respectively. The data also reveal the formation of poly-NEDD8, hybrid NEDD8-ubiquitin, and NEDD8-SUMO-2 chains as potential molecular signals. In particular, NEDD8-SUMO-2 chains are induced upon proteotoxic stress (atypical) through NEDDylation of K11 in SUMO-2, and conjugates accumulate in previously described nucleolus-related inclusions. The study uncovers a diverse proteome for NEDDylation and is consistent with the concept of extensive cross-talk between ubiquitin and Ubls under proteotoxic stress conditions.

Identifiants

pubmed: 33472076
pii: S2211-1247(20)31624-7
doi: 10.1016/j.celrep.2020.108635
pii:
doi:

Substances chimiques

NEDD8 Protein 0
NEDD8 protein, human 0
Proteome 0
SUMO2 protein, human 0
Small Ubiquitin-Related Modifier Proteins 0
Endopeptidases EC 3.4.-
SENP8 protein, human EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108635

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Sofia Lobato-Gil (S)

CRBM, University of Montpellier, CNRS, Montpellier, France.

Jan B Heidelberger (JB)

Institute of Molecular Biology (IMB), Mainz, Germany.

Chantal Maghames (C)

CRBM, University of Montpellier, CNRS, Montpellier, France.

Aymeric Bailly (A)

CRBM, University of Montpellier, CNRS, Montpellier, France.

Lorene Brunello (L)

CRBM, University of Montpellier, CNRS, Montpellier, France.

Manuel S Rodriguez (MS)

Laboratoire de Chimie de Coordination (LCC), UPR 8241, CNRS, Toulouse, France; IPBS-University of Toulouse III-Paul Sabatier, Toulouse, France.

Petra Beli (P)

Institute of Molecular Biology (IMB), Mainz, Germany. Electronic address: p.beli@imb-mainz.de.

Dimitris P Xirodimas (DP)

CRBM, University of Montpellier, CNRS, Montpellier, France. Electronic address: dimitris.xirodimas@crbm.cnrs.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH